TY - JOUR
T1 - Cervix Cancer Research Network (CCRN)
T2 - Improving Access to Cervix Cancer Trials on a Global Scale
AU - Gaffney, David
AU - Small, Bill
AU - Kitchener, Henry
AU - Young Ryu, Sang
AU - Viswanathan, Akila
AU - Trimble, Ted
AU - Covens, Al
AU - Wilailak, Sarikapan
AU - Lertkhachonsuk, Arb Aroon
AU - Sitathanee, Chomporn
AU - Mahantshetty, Umesh
AU - Fisher, Brandon
AU - Springer, Susan
AU - Pollatz, Thomas
AU - Spiller, Antonius
AU - Bacon, Monica
AU - Jhingran, Anuja
N1 - Publisher Copyright:
Copyright © 2016 by IGCS and ESGO.
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Eighty-seven percent of cervix cancer occurs in less-developed regions of the world, and there is up to an 18-fold difference in mortality rate for cervix cancer depending on the region of the world. The Cervix Cancer Research Network (CCRN) was founded through the Gynecologic Cancer InterGroup with the aim of improving access to clinical trials in cervix cancer worldwide, and in so doing improving standards of care. The CCRN recently held its first international educational symposium in Bangkok. Sixty-two participants attended from 16 different countries including Pakistan, India, Bangladesh, Thailand, Malaysia, Singapore, Philippines, Taiwan, China, Vietnam, Korea, Japan, Columbia, Brazil, Canada, and the United States. The focus of this symposium was to evaluate progress, to promote new clinical trials for the CCRN, and to provide education regarding the role of brachytherapy in the treatment of cervical cancer.
AB - Eighty-seven percent of cervix cancer occurs in less-developed regions of the world, and there is up to an 18-fold difference in mortality rate for cervix cancer depending on the region of the world. The Cervix Cancer Research Network (CCRN) was founded through the Gynecologic Cancer InterGroup with the aim of improving access to clinical trials in cervix cancer worldwide, and in so doing improving standards of care. The CCRN recently held its first international educational symposium in Bangkok. Sixty-two participants attended from 16 different countries including Pakistan, India, Bangladesh, Thailand, Malaysia, Singapore, Philippines, Taiwan, China, Vietnam, Korea, Japan, Columbia, Brazil, Canada, and the United States. The focus of this symposium was to evaluate progress, to promote new clinical trials for the CCRN, and to provide education regarding the role of brachytherapy in the treatment of cervical cancer.
KW - Brachytherapy
KW - CCRN
KW - Cervical cancer
KW - Cervix cancer
KW - Radiotherapy
UR - http://www.scopus.com/inward/record.url?scp=84994643796&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84994643796&partnerID=8YFLogxK
U2 - 10.1097/IGC.0000000000000823
DO - 10.1097/IGC.0000000000000823
M3 - Article
C2 - 27779548
AN - SCOPUS:84994643796
SN - 1048-891X
VL - 26
SP - 1690
EP - 1693
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
IS - 9
ER -